BioLineRx Ltd. (NASDAQ:BLRX) Q1 2023 Earnings Call Transcrip

Operator: Ladies and gentlemen, thank you for standing by. Welcome to the BioLineRx First Quarter 2023 Financial Results Conference Call.

Related Keywords

China , Israel , Mali , Kevin Campbell , Phil Serlin , Eric Sapp , Mark Breidenbach , Genzyme Sanofi , Joe Pantginis , John Lacey , Ella Sorani , Tami Rachmilewitz , Philip Serlin , John Vandermosten , Nasdaq , Corporate Communications Biolinerx , Washington University School Of Medicine , Columbia University , Market Development , Program Scientific Advisory Board , Biolinerx Ltd , Call Transcript May , Biolinerx First Quarter , Results Conference , Investor Relations , Corporate Communications , Chief Executive Officer , Mali Zeevi , Chief Financial Officer , Chief Development Officer , Holly May , Biolinerx United States , Chief Medical , Genesis Phase , Washington University School , Genfleet Therapeutics , Combination Study , Genfleet Phase , Kreos Capital ,